Source: Virtual Congress 2021 – Treatments for airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Turner (Birmingham, United Kingdom), M. Torres (Vigo, Spain), J. López-Campos (Sevilla, Spain), C. Guimaraes (Guimaraes, Portugal), J. Chorostowska-Wynimko (Warsaw, Poland), R. Bals (Homburg, Germany), I. Ferrarotti (Pavia, Italy), G. Mcelvaney (Dublin, Ireland), K. O'Hara (Coventry, United Kingdom), J. Stolk (Leiden, Netherlands), R. Stockley (Birmingham, United Kingdom), M. Wilkens (Berlin, Germany), C. Clarenbach (Zurich, Switzerland), T. Greulich (Marburg, Germany), M. Miravitlles (Barcelona (CT), Spain). Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results.. 1834

Member's Comments

No comment yet.

Related content which might interest you: Baseline characteristics of subjects with α1-antitrypsin deficiency included in the alpha one international registry (AIR) Source: Eur Respir J 2003; 22: Suppl. 45, 487s Year: 2003 Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020 The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016 Year: 2017 Characteristics of COPD patients from primary care enrolled in a prospective multicenter cohort study Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 PP229 – Clinical profile of 116 patients undergoing post-COVID follow-up - A prospective study Source: ERS Lung Science Conference 2021 Year: 2021 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 COVID-19 pneumonia and clinical follow-up: results of a prospective cohort Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 Characteristics of COPD patients and alpha-1 antitrypsin deficiency at outpatient respiratory clinics. The EPOCONSUL study. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Clinical differences in sarcoidosis patients with and without lymphoma: a single-centre retrospective cohort analysis Source: Eur Respir J, 54 (5) 1802470; 10.1183/13993003.02470-2018 Year: 2019 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012